In an interview with Rolling Stone, Katharine Neill Harris, the Alfred C. Glassell, III, Fellow in Drug Policy, elaborated on her proposal to launch a pilot program to study the safety and efficacy of heroin-assisted treatment (HAT) in the United States. Several European nations have already launched HAT programs that have shown to have a significant impact on reducing opioid use and overdoses. "For certain people, heroin is preferable," Neill Harris said. "It could help them stay in treatment for longer."
Read more on the topic in a post authored by Neill Harris for the Baker Institute Blog: http://bit.ly/2uRr1Li.
Kirstin R.W. Matthews , Ana S. Iltis
Apr 23 2021 | Science & Technology Policy
Peter J. Hotez
Apr 22 2021 | Center for Health and Biosciences